Anxiety |
|
|
|
|
Time in Closed Arm on EPM |
↑ |
↓ |
↑ |
↓ |
Social Behaviour |
|
|
|
|
Social Interaction (General Investigation) |
– |
– |
↑ |
– |
Social Interaction (Anogenital Sniffing) |
↑ |
– |
↑ |
– |
Social Interaction (Aggressive behaviour) |
↑ |
– |
↑ |
– |
Methamphetamine addiction outcomes |
|
|
|
|
Methamphetamine self-administration (0.03 mg/kg) |
↑ |
– |
– |
– |
Methamphetamine self-administration (0.1 mg/kg) |
↑ |
↓ |
– |
– |
Lifetime methamphetamine intake (mg/kg) |
↑ |
↓ |
– |
– |
Days to extinction criterion |
↑ |
↓ |
– |
– |
Cue-induced reinstatement |
↑ |
– |
– |
– |
Meth-primed reinstatement (0.3 mg/kg) |
– |
- |
- |
- |
Meth-primed reinstatement (1 mg/kg) |
↑ |
↓ |
↑ |
↓ |
Yohimbine-primed reinstatement (0.625 mg/kg) |
– |
– |
↑ |
↓ |
Yohimbine-primed reinstatement (1.25 mg/kg) |
↑ |
↓ |
↑ |
– |
Brain and blood markers |
|
|
|
|
Hypothalamic oxytocin cell counts |
↓ |
↑ |
↓ |
– |
Hypothalamic CRF cell counts |
↑ |
– |
↑ |
– |
Plasma oxytocin levels |
↑ |
↓ |
– |
– |
Plasma corticosterone levels |
↑ |
↓ |
↑ |
↓ |